Aemetis (NASDAQ:AMTX) shares are trading higher on Tuesday after the company announced it received an FDA national drug code for its OTC sanitizer products.
Aemetis's stock traded up 27.07% at $2.11 per share at the time of publication on Tuesday. The stock has a 52-week high of $3.47 and a 52-week low of 37 cents.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
